From MarketBeat:

Maximus Stock Down 7.3 % on Thursday, downgraded from “buy” to “hold” by StockNews.com, following other analysts’ ratings changes. NYSE:MMS opened at $77.33, with a 52-week low of $70.86. Maximus had a net margin of 3.30% and revenue of $1.26 billion, falling short of analysts’ $1.27 billion estimate.

Insider Ilene R. Baylinson sold 10,043 shares of Maximus at $85.57, following the company’s last earnings report, which fell below analyst expectations. 5.32 earnings per share is anticipated for the current fiscal year.

Institutional investors are making changes to their positions in the company, with Farther Finance Advisors LLC and VisionPoint Advisory Group LLC increasing stakes in the company over the past year. Hedge funds and other institutional investors own 99.30% of the stock.

Maximus, Inc, operates as a provider of government services in the United States and internationally, operating through three segments. The company is a strong player in the healthcare and related services industry, having reported a net margin of 3.30% over the past quarter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This company story was reviewed prior to publication. Please send any questions or comments about this story to [email protected].



Read more: Maximus (NYSE:MMS) Lowered to “Hold” at StockNews.com